Evaluation of the clinical advantage of endo-rectal balloons (ERBs) for prostate treatments.

Authors

null

Sarah J Barton

Christie NHS Foundation Trust, Manchester, United Kingdom

Sarah J Barton , Julia Stratford , Douglas Brand , Catherine Thompson , Cathy Taylor , John P. Logue , James Wylie , Catherine Coyle , Alan McWilliam , Ananya Choudhury

Organizations

Christie NHS Foundation Trust, Manchester, United Kingdom, The Christie NHS Foundation Trust, Manchester, United Kingdom, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom, Christie Hospital, Manchester, United Kingdom

Research Funding

No funding sources reported

Background: The challenge of prostate and rectal motion during radiotherapy has been firmly established, both these problems are exacerbated by rectal instability. A number of different mechanical methods have been explored to see if the rectum can be stabilised. This study aimed to establish whether there is a clinical advantage in the use of ERB’s for the treatment of prostate patients, assessing inter-fractional prostate stability and dose to the rectum. Methods: This planning study was based on 10 patients with 2 sets of CT and Cone beam CT (CBCT) data with and without an ERB in situ. The ERB was a 100cc air filled RectalPro balloon. CBCT scan with and without the ERB were taken on the same day. The scans were contoured and planned using pinnacle version 9.8 with rotational arc therapy to a dose of 60Gy in 20 fractions, for an Elekta Agility treatment unit. An assumption was made that the prostate stability was directly related to the rectal stability. Based on this assumption, comparisons of the rectal position and dose on the CBCT verses the respective CBCT were made. The rectal DVH on the plans for the ERB verses no ERB were compared and a two-tailed T-test was used for statistical analysis of all comparisons. Results: Positional analysis demonstrated 12% improvement in the dice coefficient similarity score of the rectum for the ERB (P=0.0003). This only correlated to a significant improvement in the AP movement at mid prostate for the ERBs (P=0.031). The ERB position was seen to be influenced by the angle of insertion. Removal of the CBCT data from the 4 ERBs with largest deviations in insertion angle significantly reduced the inter-fractional movement seen with the ERBs. The lower rectal doses showed an improvement of around 8% for the ERB group, although for the 57Gy dose was 2.5% better with no-ERB as shown in the Table. Conclusions: There is a clinical and statistical benefit in the dose reduction for the rectal wall in the use of ERB’s for prostate radiotherapy. Although the ERB position needs to be confirmed with IGRT to remove the potential for inter-fractional positional error.

Dose
(in Gy)
Mean % dose
p value
No ERBERB
24.672.265.70.0021
32.459.350.50.0009
40.843.936.90.0095
48.630.427.30.185
52.819.3170.286
57.04.87.20.166

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 34, 2016 (suppl 2S; abstr 148)

DOI

10.1200/jco.2016.34.2_suppl.148

Abstract #

148

Poster Bd #

C7

Abstract Disclosures

Similar Abstracts

First Author: Tingyu WANG

First Author: Prantik Das

Abstract

2023 ASCO Quality Care Symposium

Understanding radiation treatment terminations as an element of quality.

First Author: William Chun-Ying Chen